These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20879245)

  • 1. Characterizing the regional structural difference of the brain between tau transgenic (rTg4510) and wild-type mice using MRI.
    Xie Z; Yang D; Stephenson D; Morton D; Hicks C; Brown T; Bocan T
    Med Image Comput Comput Assist Interv; 2010; 13(Pt 1):308-15. PubMed ID: 20879245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510).
    Yang D; Xie Z; Stephenson D; Morton D; Hicks CD; Brown TM; Sriram R; O'Neill S; Raunig D; Bocan T
    Neuroimage; 2011 Feb; 54(4):2652-8. PubMed ID: 21035554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the accumulation and suppression of tau pathology using multiparametric MRI.
    Holmes HE; Colgan N; Ismail O; Ma D; Powell NM; O'Callaghan JM; Harrison IF; Johnson RA; Murray TK; Ahmed Z; Heggenes M; Fisher A; Cardoso MJ; Modat M; Walker-Samuel S; Fisher EM; Ourselin S; O'Neill MJ; Wells JA; Collins EC; Lythgoe MF
    Neurobiol Aging; 2016 Mar; 39():184-94. PubMed ID: 26923415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
    Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
    J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510).
    Kim J; Choi IY; Duff KE; Lee P
    Neurochem Res; 2017 Jun; 42(6):1649-1660. PubMed ID: 28523532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison.
    Grandjean J; Derungs R; Kulic L; Welt T; Henkelman M; Nitsch RM; Rudin M
    Neuroimage; 2016 Jul; 134():1-11. PubMed ID: 27033685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease.
    Lau JC; Lerch JP; Sled JG; Henkelman RM; Evans AC; Bedell BJ
    Neuroimage; 2008 Aug; 42(1):19-27. PubMed ID: 18547819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
    Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
    J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
    Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
    J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo.
    DeVos SL; Corjuc BT; Commins C; Dujardin S; Bannon RN; Corjuc D; Moore BD; Bennett RE; Jorfi M; Gonzales JA; Dooley PM; Roe AD; Pitstick R; Irimia D; Frosch MP; Carlson GA; Hyman BT
    Brain; 2018 Jul; 141(7):2194-2212. PubMed ID: 29733334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
    Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
    PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease.
    Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM
    Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of manual and semi-automated segmentation methods to evaluate hippocampus volume in APP and PS1 transgenic mice obtained via in vivo magnetic resonance imaging.
    Hayes K; Buist R; Vincent TJ; Thiessen JD; Zhang Y; Zhang H; Wang J; Summers AR; Kong J; Li XM; Martin M
    J Neurosci Methods; 2014 Jan; 221():103-11. PubMed ID: 24091139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.
    Baker S; Polanco JC; Götz J
    J Alzheimers Dis; 2016 Oct; 54(3):1207-1217. PubMed ID: 27567840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.